This week we speak to Gary Coventry, former Head of Product Development and Innovation at MELA Sciences, a biotech firm centered around melanoma detection that received millions in funding and even IPOed. Unfortunately, they eventually fell into a downward spiral and was forced to rebrand. Listen to the story of the downward spiral of MELA in this episode. 

Crashpad

Crashpad: Gary Coventry, Former Head of Product Dev and Innovation at MELA Sciences

We interview founders and employees of startups that were crushed by the market to get a picture of what led to the startup’s demise and other valuable lessons. Music from https://filmmusic.io "Nowhere Land" by Kevin MacLeod (https://incompetech.com) License: CC BY (http://creativecommons.org/licenses/by/4.0/)

About

Crashpad